Common Contracts
3 similar Stock Purchase Agreement contracts by Spero Therapeutics, Inc.
EX-10.13 14 d431217dex1013.htm EX-10.13 CONFIDENTIAL TREATMENT REQUESTED STOCK PURCHASE AGREEMENT among SPERO CANTAB, INC., SPERO CANTAB UK LIMITED, SPERO THERAPEUTICS, LLC, PBB DISTRIBUTIONS LIMITED, NEW PHARMA LICENSE HOLDINGS LIMITED, CANTAB...Stock Purchase Agreement • May 5th, 2020 • England and Wales
This STOCK PURCHASE AGREEMENT, dated as of June 6, 2016 (this “Agreement”), is among SPERO CANTAB, INC., a Delaware corporation (“Spero”); SPERO CANTAB UK LIMITED, a company organized under the laws of England and Wales, having registration number 10175336 and a wholly-owned subsidiary of Spero (“Purchaser”); solely for purposes of Section 7.14, SPERO THERAPEUTICS, LLC, a Delaware limited liability company (“Spero Therapeutics”); PBB DISTRIBUTIONS LIMITED, a company organized under the laws of Malta and having registration number C 75891 and a wholly-owned subsidiary of Parent (“Seller”); NEW PHARMA LICENSE HOLDINGS LIMITED, a company organized under the laws of Malta and having registration number C47138 (the “Company”); CANTAB ANTI-INFECTIVES LTD, a company organized under the laws of England and having registration number 8217622 (“CAI”); and, solely for purposes of Article VI, PRO BONO BIO PLC, a company organized under the laws of England and having registration number 8705972 (“P
CONFIDENTIAL TREATMENT REQUESTED STOCK PURCHASE AGREEMENT among SPERO CANTAB, INC., SPERO CANTAB UK LIMITED, SPERO THERAPEUTICS, LLC, PBB DISTRIBUTIONS LIMITED, NEW PHARMA LICENSE HOLDINGS LIMITED, CANTAB ANTI-INFECTIVES LTD, and PRO BONO BIO PLC...Stock Purchase Agreement • September 29th, 2017 • Spero Therapeutics, Inc. • Pharmaceutical preparations • England and Wales
Each of the Milestone Payments shall be payable a maximum of one (1) time only even if achieved more than one (1) time with one or more Products. For the avoidance of doubt, (x) each of the Milestone Payments shall become payable upon the occurrence of the associated Milestone Event, irrespective of the order in which the Milestone Events occur relative to each other, and (y) no amounts shall be due for subsequent or repeated achievements of any Milestone Event.
CONFIDENTIAL TREATMENT REQUESTED STOCK PURCHASE AGREEMENT among SPERO CANTAB, INC., SPERO CANTAB UK LIMITED, SPERO THERAPEUTICS, LLC, PBB DISTRIBUTIONS LIMITED, NEW PHARMA LICENSE HOLDINGS LIMITED, CANTAB ANTI-INFECTIVES LTD, and PRO BONO BIO PLC...Stock Purchase Agreement • September 22nd, 2017 • Spero Therapeutics, Inc. • Pharmaceutical preparations • England and Wales
Each of the Milestone Payments shall be payable a maximum of one (1) time only even if achieved more than one (1) time with one or more Products. For the avoidance of doubt, (x) each of the Milestone Payments shall become payable upon the occurrence of the associated Milestone Event, irrespective of the order in which the Milestone Events occur relative to each other, and (y) no amounts shall be due for subsequent or repeated achievements of any Milestone Event.
